Every 10-Q that PYXUS INTL INC NEW (PYYX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PYYX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PYYX filings page.
Pyxus International, Inc. reported fiscal first‑quarter 2027 results for the three months ended June 30, 2026. Sales and other operating revenues were $437.8 million, down 14.0% from $508.8 million, mainly from lower leaf tobacco prices in South America and Africa and shipment timing in North America. Gross profit was $61.4 million versus $65.6 million, with margin improving to 14.0% from 12.9%. Operating income was $15.7 million, and the net loss attributable to Pyxus narrowed to $7.3 million, or $0.28 per share, from a $15.8 million loss, helped by a $5.7 million income tax benefit and higher income from unconsolidated affiliates.
Unprocessed tobacco inventories were $393.5 million and processed tobacco $671.6 million; management notes total tobacco inventories declined $24.6 million, or 2.3%, year over year, with higher carry‑over processed volumes and slower green purchases. Debt totaled $1,284.6 million and cash and equivalents $175.9 million, resulting in net debt of $1,108.7 million. Net cash used in operating activities was $359.7 million, reflecting seasonal working‑capital build, funded largely by $353.6 million of net short‑term borrowings and $58.5 million of collections from securitized receivables. Management highlights elevated Southern Hemisphere crop production, higher uncommitted processed inventory of $60.3 million, reliance on foreign seasonal lines of credit with $351.4 million remaining available, and potential weather impacts from a forecast “Super” El Niño as key considerations.
Pyxus International, Inc. reported lower sales but stable quarterly profitability in its latest period. For the three months ended December 31, 2025, sales and other operating revenues fell 15.7% to $655.8 million, mainly from lower leaf tobacco volumes and prices, while gross margin ticked up to 15.2% due to favorable mix and stronger processing revenues.
Quarterly net income attributable to Pyxus was $16.9 million, down 10.6% from the prior year, but year-to-date profit dropped sharply to $0.2 million from $20.3 million as lower volumes, shipment timing and higher other expenses weighed on results. Operating cash flow was deeply negative at $(518.6) million for the nine-month period, driven by a large build in inventories and advances to suppliers tied to bigger crops.
Net debt rose to $1.16 billion, up from $960.0 million a year earlier, as the company relied more heavily on foreign seasonal lines of credit. Total tobacco inventories reached $959.8 million as of December 31, 2025, positioning Pyxus to support anticipated higher shipments later in the fiscal year but increasing working capital intensity and leverage.
Pyxus International filed its 10‑Q reporting Q2 FY2026 results. Sales and other operating revenues were $570.2 million, up 0.7% year over year, as higher volumes and processing revenues offset lower average sales prices. Gross margin improved to 15.4% from 13.3%, and operating income rose to $46.7 million. After $37.9 million of interest expense and $10.3 million of income tax expense, the company reported a net loss of $0.9 million, or $(0.03) per share.
For the first six months, sales were $1,079.0 million, down 10.2%, with a net loss of $16.7 million. Working capital peaked seasonally: inventories increased to $1,135.2 million, and notes payable rose to $908.0 million. Net cash used in operating activities was $580.9 million, reflecting procurement in Africa and South America and timing of shipments. Long‑term debt was $455.3 million and the company remained in compliance with covenants.
The ABL Credit Facility was amended on May 12, 2025 to increase commitments to $150 million and extend maturity to 2030, and two receivables securitization programs remained active. As of October 31, 2025, common shares outstanding were 24,607,791.